abstract |
The present invention relates to NNRTI, designated TMC278, useful for the treatment of HIV-infected patients or for preventing HIV transmission or infection, as nucleoside reverse transcriptase inhibitors such as emtricitabine, lamivudine or abakavir and / or nucleotide reverse transcriptase inhibitors. And to pyrimidine blends comprising tenofovir. |